Kiyohiko Hatake

3.6k total citations · 1 hit paper
130 papers, 2.3k citations indexed

About

Kiyohiko Hatake is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Kiyohiko Hatake has authored 130 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 44 papers in Molecular Biology and 28 papers in Hematology. Recurrent topics in Kiyohiko Hatake's work include Cancer Treatment and Pharmacology (24 papers), Colorectal Cancer Treatments and Studies (22 papers) and Acute Myeloid Leukemia Research (12 papers). Kiyohiko Hatake is often cited by papers focused on Cancer Treatment and Pharmacology (24 papers), Colorectal Cancer Treatments and Studies (22 papers) and Acute Myeloid Leukemia Research (12 papers). Kiyohiko Hatake collaborates with scholars based in Japan, United States and India. Kiyohiko Hatake's co-authors include Kazuo Motoyoshi, Fumihiko Kimura, Alan H. Drummond, Shigekazu Nagata, Norio Nakamura, Masato Tanaka, Takashi Suda, Kyosuke Haze, Masao Mizuki and S Tagawa and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Kiyohiko Hatake

128 papers receiving 2.2k citations

Hit Papers

Fas ligand in human serum 1996 2026 2006 2016 1996 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyohiko Hatake Japan 24 912 777 760 313 288 130 2.3k
Masaaki Higashihara Japan 25 675 0.7× 542 0.7× 477 0.6× 618 2.0× 412 1.4× 127 2.1k
Ernest Brahn United States 28 702 0.8× 839 1.1× 542 0.7× 193 0.6× 250 0.9× 64 2.5k
William L. Trepicchio United States 26 969 1.1× 1.8k 2.3× 785 1.0× 286 0.9× 395 1.4× 61 3.2k
Paloma Martín Spain 25 740 0.8× 437 0.6× 712 0.9× 414 1.3× 112 0.4× 59 2.2k
Nick J. Gonchoroff United States 28 791 0.9× 469 0.6× 562 0.7× 339 1.1× 378 1.3× 41 2.4k
Ηλίας Δράκος United States 28 1.1k 1.2× 420 0.5× 648 0.9× 457 1.5× 123 0.4× 71 2.1k
Linda K. Myers United States 31 651 0.7× 1.4k 1.8× 430 0.6× 225 0.7× 199 0.7× 102 3.2k
Ping Zhu China 34 1.4k 1.5× 1.8k 2.3× 532 0.7× 277 0.9× 380 1.3× 142 3.7k
Steven J. Schrodi United States 26 878 1.0× 1.4k 1.9× 314 0.4× 225 0.7× 304 1.1× 67 3.0k
Philipp B. Staber Austria 23 804 0.9× 356 0.5× 593 0.8× 395 1.3× 390 1.4× 88 1.9k

Countries citing papers authored by Kiyohiko Hatake

Since Specialization
Citations

This map shows the geographic impact of Kiyohiko Hatake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyohiko Hatake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyohiko Hatake more than expected).

Fields of papers citing papers by Kiyohiko Hatake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyohiko Hatake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyohiko Hatake. The network helps show where Kiyohiko Hatake may publish in the future.

Co-authorship network of co-authors of Kiyohiko Hatake

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyohiko Hatake. A scholar is included among the top collaborators of Kiyohiko Hatake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyohiko Hatake. Kiyohiko Hatake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugano, Naoki, et al.. (2020). New Concept of Onco-Hypertension and Future Perspectives. Hypertension. 77(1). 16–27. 47 indexed citations
2.
Oka, Toru, Hiroshi Akazawa, Kazuhiro Sase, Kiyohiko Hatake, & Issei Komuro. (2020). Cardio-Oncology in Japan. JACC CardioOncology. 2(5). 815–818. 7 indexed citations
3.
Kubo, Kohmei, Mitsuo Hori, Kensuke Ohta, et al.. (2019). Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan. International Journal of Hematology. 111(1). 65–74. 10 indexed citations
4.
Kasuda, Shogo, et al.. (2019). Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis. Bulletin of Experimental Biology and Medicine. 166(5). 667–670. 1 indexed citations
5.
Kasuda, Shogo, et al.. (2018). Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Secrete Sphingosine-1-Phosphate and Revert Endothelial Injury. Bulletin of Experimental Biology and Medicine. 164(6). 775–779. 2 indexed citations
6.
Kasuda, Shogo, et al.. (2015). Ethanol attenuates vasorelaxation via inhibition of inducible nitric oxide synthase in rat artery exposed to interleukin-1β. Human & Experimental Toxicology. 35(9). 938–945. 4 indexed citations
7.
Takahashi, Shunji, Masaki Miyazaki, Isamu Okamoto, et al.. (2011). Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors. Cancer Science. 102(11). 2058–2064. 19 indexed citations
8.
Yuasa, Takeshi, Shinya Maita, Norihiko Tsuchiya, et al.. (2010). Relationship Between Bone Mineral Density and Androgen-deprivation Therapy in Japanese Prostate Cancer Patients. Urology. 75(5). 1131–1137. 16 indexed citations
9.
Ito, Yoshinori, Koichi Nagasaki, Yoshio Miki, et al.. (2010). Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer. Cancer Science. 102(1). 130–136. 2 indexed citations
10.
11.
Matsusaka, Satoshi, Chie Watanabe, Mitsukuni Suenaga, et al.. (2008). [Relative dose intensity of FOLFOX4 regimen].. PubMed. 35(11). 1895–900. 1 indexed citations
12.
Hatake, Kiyohiko, Norio Yamamoto, S. Takahashi, et al.. (2008). 422 POSTER A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumours. European Journal of Cancer Supplements. 6(12). 133–133. 2 indexed citations
13.
Hatake, Kiyohiko, Nahomi Tokudome, & Yoshinori Ito. (2007). Next generation molecular targeted agents for breast cancer: focus on EGFR and VEGFR pathways. Breast Cancer. 14(2). 132–149. 21 indexed citations
14.
Toi, Masakazu, Toshiaki Saeki, Kenjiro Aogi, et al.. (2005). Late Phase II Clinical Study of Vinorelbine Monotherapy in Advanced or Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes. Japanese Journal of Clinical Oncology. 35(6). 310–315. 29 indexed citations
15.
Nagasaki, Eijiro, Kiyohiko Hatake, Hideyuki Minami, et al.. (2004). フラボピリドール(HMR1275、サイクリン依存性キナーゼ(CDK)阻止剤)の毎週1時間点滴の第I相臨床試験. Journal of Clinical Oncology. 22(14). 234. 1 indexed citations
16.
Tabata, Masahiko, Yusuke Furukawa, Kiyohiko Hatake, et al.. (2001). Stimulation of GATA-2 as a mechanism of hydrogen peroxide suppression in hypoxia-induced erythropoietin gene expression. Journal of Cellular Physiology. 186(2). 260–267. 29 indexed citations
17.
Tabata, Masahiko, Hironori Takahashi, Toru Izumi, et al.. (1999). Adult T Cell Leukemia Lymphoma (ATL) Localized in the Right Tibial Bone. Leukemia & lymphoma. 35(1-2). 189–192. 3 indexed citations
18.
Yamashita, Yoshihiro, Sumiko Watanabe, Akira Miyazato, et al.. (1998). Tec and Jak2 Kinases Cooperate to Mediate Cytokine-Driven Activation of c-fos Transcription. Blood. 91(5). 1496–1507. 38 indexed citations
19.
Tanaka, Masato, Takashi Suda, Kyosuke Haze, et al.. (1996). Fas ligand in human serum. Nature Medicine. 2(3). 317–322. 601 indexed citations breakdown →
20.
Ohtsuki, T., Kiyohiko Hatake, Shinya Suzu, et al.. (1994). Alteration of the proteoglycan form of macrophage colony-stimulating factor produced by a human stromal line stimulated by tumor necrosis factor-alpha.. PubMed. 22(4). 366–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026